PORTLAND, IL, UNITED STATES, February 3, 2025 /EINPresswire / -- According to the recent report released by Allied market Research, the global transdermal drug delivery systems market size is ...
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent: New York Tuesday, January 28, 2025, 17:00 Hrs [IST] Anavex Life Sciences Corp., a clin ...
As they prepare for Phase One clinical trials, Corsair Pharma is prioritizing safety, tolerability, and quality at every stage of development. To support these critical goals, the company has ...